Herantis Pharma Oyj Capital Reinvestment Ratio

Latest as of December 2013: 2299.45x

Herantis Pharma Oyj capital reinvestment ratio. Herantis Pharma Oyj (HRTIS) has a Capital Reinvestment Ratio of 2299.45x as of December 2013, meaning it reinvests 2299% of its operating cash flow (€183.24) in capital expenditures (€421.35K). See HRTIS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2299.45x

Capex / Operating Cash Flow

Operating Cash Flow

€183.24

EUR

Capital Expenditures

€421.35K

EUR

Data as of

Dec 2013

Most recent filing

Herantis Pharma Oyj Capital Reinvestment Ratio by Year (None–None)

Herantis Pharma Oyj capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see HRTIS cash flow conversion.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow